Hong Kong's innovative pharmaceutical stocks experienced a strong start in early trading, with several companies showing significant gains. According to Jin10, CStone Pharmaceuticals-B (02616.HK) saw an increase of over 13%, while Hua Medicine (02552.HK) rose by more than 11%. Everest Medicines (01952.HK) also climbed over 7%. Additionally, several other stocks, including Kintor Pharmaceutical (09939.HK), Mabpharm (02181.HK), Laekna Therapeutics (02105.HK), and Sorrento Therapeutics (06669.HK), recorded gains exceeding 5%.